Global Ophthalmic Drugs Market Size study, by Drug Class, by Product Type and Regional Forecasts 2022-2032

Description

List of Tables

Global Ophthalmic Drugs Market is valued at approximately USD 38 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.10% over the forecast period 2024-2032. Ophthalmic drugs are medications specifically designed to treat eye conditions and diseases. These drugs can be administered through various routes such as eye drops, ointments, gels, or injections directly into the eye. They are used to manage a wide range of eye-related issues including infections, inflammation, glaucoma, allergies, dry eye syndrome, and other eye disorders. Also, the development of biologic drugs and targeted therapies for various eye diseases such as Age-Related Macular Degeneration (AMD), and diabetic retinopathy has been a significant trend of Ophthalmic Drugs Market. These therapies offer more precise targeting of underlying disease mechanisms, potentially improving efficacy and reducing side effects compared to traditional treatments.

Moreover, as the global population ages and lifestyles change, the prevalence of eye disorders such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy increases, driving the demand for ophthalmic drugs. Also, advances in drug delivery techniques, such as sustained-release formulations and nanoparticle-based therapies, enhance the efficacy and convenience of ophthalmic drugs, encouraging their adoption. Other factors supporting the market growth are rising healthcare expenditure, growing awareness, and screening programs, expanding geriatric population, and increasing adoption of combination therapies. However, the risks associated with ophthalmic drugs, and the longer timeline required for the formulation of ophthalmic drugs are expected to hinder the growth of Ophthalmic Drugs market during the forecast period 2024-2032.

The key regions considered for the global Ophthalmic Drugs market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the Ophthalmic Drugs Market in 2023 and is projected to maintain its leadership throughout the forecast period. This dominance is primarily attributed to factors such as the growing elderly population, a rise in the incidence of eye diseases, and government initiatives aimed at promoting eye health. Moreover, increased awareness about the prevention and treatment of eye conditions, coupled with a rising demand for advanced healthcare facilities, further propels market growth in the region. Additionally, heightened research and development activities in the healthcare sector, aimed at innovating new ophthalmic drugs, along with the presence of established industry players, contribute significantly to market expansion. On the other hand, the Asia-Pacific region is expected to witness the highest CAGR. This growth trajectory is driven by factors such as the increasing prevalence of glaucoma and rising awareness regarding ophthalmic drugs among people.

Major market player included in this report are:

Pfizer Inc.
Alcon Inc.
Novartis AG
Bausch Health Companies Inc.
Merck & Co., Inc.
Regeneron Pharmaceuticals Inc.
Allergan plc
Bayer AG
Genentech, Inc.
Nicox SA

The detailed segments and sub-segment of the market are explained below:

By Drug Class

Anti-glaucoma Drugs
Dry Eye Drugs
Ophthalmic Anti-allergy/Inflammatory
Retinal Drugs
Anti-infective Drugs
Other Drugs

By Product Type

OTC Drugs
Prescription Drugs

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

Chapter 1. Global Ophthalmic Drugs Market Definition and Research Assumptions

1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
- 1.3.1. Inclusion & Exclusion
- 1.3.2. Limitations
- 1.3.3. Supply Side Analysis
  - 1.3.3.1. Availability
  - 1.3.3.2. Infrastructure
  - 1.3.3.3. Regulatory Environment
  - 1.3.3.4. Market Competition
  - 1.3.3.5. Economic Viability (Consumer's Perspective)
- 1.3.4. Demand Side Analysis
  - 1.3.4.1. Regulatory frameworks
  - 1.3.4.2. Technological Advancements
  - 1.3.4.3. Environmental Considerations
  - 1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary

2.1. Global Ophthalmic Drugs Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
- 2.3.1. By Drug Class
- 2.3.2. By Product Type
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Ophthalmic Drugs Market Dynamics

3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities

Chapter 4. Global Ophthalmic Drugs Market Industry Analysis

4.1.1. Porter's 5 Force Model
4.1.2. Bargaining Power of Suppliers
4.1.3. Bargaining Power of Buyers
4.1.4. Threat of New Entrants
4.1.5. Threat of Substitutes
4.1.6. Competitive Rivalry
4.1.7. Futuristic Approach to Porter's 5 Force Model
4.1.8. Porter's 5 Force Impact Analysis

4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Ophthalmic Drugs Market Size & Forecasts by Drug Class 2022-2032

5.1. Anti-glaucoma Drugs
5.2. Dry Eye Drugs
5.3. Ophthalmic Anti-allergy/Inflammatory
5.4. Retinal Drugs
5.5. Anti-infective Drugs
5.6. Other Drugs

Chapter 6. Global Ophthalmic Drugs Market Size & Forecasts by Product Type 2022-2032

6.1. OTC Drugs
6.2. Prescription Drugs

Chapter 7. Global Ophthalmic Drugs Market Size & Forecasts by Region 2022-2032

7.1. North America Ophthalmic Drugs Market
- 7.1.1. U.S. Ophthalmic Drugs Market
  - 7.1.1.1. Drug Class breakdown size & forecasts, 2022-2032
  - 7.1.1.2. Product Type breakdown size & forecasts, 2022-2032
- 7.1.2. Canada Ophthalmic Drugs Market
7.2. Europe Ophthalmic Drugs Market
- 7.2.1. U.K. Ophthalmic Drugs Market
- 7.2.2. Germany Ophthalmic Drugs Market
- 7.2.3. France Ophthalmic Drugs Market
- 7.2.4. Spain Ophthalmic Drugs Market
- 7.2.5. Italy Ophthalmic Drugs Market
- 7.2.6. Rest of Europe Ophthalmic Drugs Market
7.3. Asia-Pacific Ophthalmic Drugs Market
- 7.3.1. China Ophthalmic Drugs Market
- 7.3.2. India Ophthalmic Drugs Market
- 7.3.3. Japan Ophthalmic Drugs Market
- 7.3.4. Australia Ophthalmic Drugs Market
- 7.3.5. South Korea Ophthalmic Drugs Market
- 7.3.6. Rest of Asia Pacific Ophthalmic Drugs Market
7.4. Latin America Ophthalmic Drugs Market
- 7.4.1. Brazil Ophthalmic Drugs Market
- 7.4.2. Mexico Ophthalmic Drugs Market
- 7.4.3. Rest of Latin America Ophthalmic Drugs Market
7.5. Middle East & Africa Ophthalmic Drugs Market
- 7.5.1. Saudi Arabia Ophthalmic Drugs Market
- 7.5.2. South Africa Ophthalmic Drugs Market
- 7.5.3. Rest of Middle East & Africa Ophthalmic Drugs Market

Chapter 8. Competitive Intelligence

8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
- 8.3.1. Pfizer Inc.
  - 8.3.1.1. Key Information
  - 8.3.1.2. Overview
  - 8.3.1.3. Financial (Subject to Data Availability)
  - 8.3.1.4. Product Summary
  - 8.3.1.5. Market Strategies
- 8.3.2. Alcon Inc.
- 8.3.3. Novartis AG
- 8.3.4. Bausch Health Companies Inc.
- 8.3.5. Merck & Co., Inc.
- 8.3.6. Regeneron Pharmaceuticals Inc.
- 8.3.7. Allergan plc
- 8.3.8. Bayer AG
- 8.3.9. Genentech, Inc.
- 8.3.10. Nicox SA

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes

LIST OF TABLES

TABLE 1. Global Ophthalmic Drugs market, report scope
TABLE 2. Global Ophthalmic Drugs market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Ophthalmic Drugs market estimates & forecasts by Drug Class 2022-2032 (USD Billion)
TABLE 4. Global Ophthalmic Drugs market estimates & forecasts by Product Type 2022-2032 (USD Billion)
TABLE 5. Global Ophthalmic Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. Global Ophthalmic Drugs market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Global Ophthalmic Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Ophthalmic Drugs market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Ophthalmic Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Ophthalmic Drugs market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Global Ophthalmic Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Global Ophthalmic Drugs market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Global Ophthalmic Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Global Ophthalmic Drugs market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. U.S. Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. U.S. Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. U.S. Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Canada Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Canada Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Canada Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 21. UK Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 22. UK Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 23. UK Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 24. Germany Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 25. Germany Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 26. Germany Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 27. France Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 28. France Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 29. France Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 30. Italy Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 31. Italy Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 32. Italy Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 33. Spain Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 34. Spain Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 35. Spain Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 36. RoE Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 37. RoE Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 38. RoE Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 39. China Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 40. China Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 41. China Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 42. India Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 43. India Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 44. India Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 45. Japan Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 46. Japan Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 47. Japan Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 48. Australia Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 49. Australia Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 50. Australia Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 51. South Korea Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 52. South Korea Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 53. South Korea Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 54.
TABLE 55. RoAPAC Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 56. RoAPAC Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 57. RoAPAC Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 58. Brazil Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 59. Brazil Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 60. Brazil Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 61. Mexico Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 62. Mexico Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 63. Mexico Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 64. RoLA Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 65. RoLA Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 66. RoLA Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 67. Saudi Arabia Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 68. Saudi Arabia Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 69. Saudi Arabia Ophthalmic Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 70. South Africa Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 71.
TABLE 72. South Africa Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 73. South Africa Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 74. RoMEA Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 75. RoMEA Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 76. RoMEA Ophthalmic Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 77. List of secondary sources, used in the study of Global Ophthalmic Drugs Market.
TABLE 78. List of primary sources, used in the study of Global Ophthalmic Drugs Market.
TABLE 79. Years considered for the study.
TABLE 80. Exchange rates considered

LIST OF FIGURES

FIG 1. Global Ophthalmic Drugs market, research methodology
FIG 2. Global Ophthalmic Drugs market, market estimation techniques
FIG 3. Global market size estimates & forecast methods.
FIG 4. Global Ophthalmic Drugs market, key trends 2023
FIG 5. Global Ophthalmic Drugs market, growth prospects 2022-2032
FIG 6. Global Ophthalmic Drugs market, porters 5 force model
FIG 7. Global Ophthalmic Drugs market, pestel analysis
FIG 8. Global Ophthalmic Drugs market, value chain analysis
FIG 9. Global Ophthalmic Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 10. Global Ophthalmic Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 11. Global Ophthalmic Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 12. Global Ophthalmic Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 13. Global Ophthalmic Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 14. Global Ophthalmic Drugs market, regional snapshot 2022 & 2032
FIG 15. North America Ophthalmic Drugs market 2022 & 2032 (USD Billion)
FIG 16. Europe Ophthalmic Drugs market 2022 & 2032 (USD Billion)
FIG 17. Asia pacific Ophthalmic Drugs market 2022 & 2032 (USD Billion)
FIG 18. Latin America Ophthalmic Drugs market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa Ophthalmic Drugs market 2022 & 2032 (USD Billion)
FIG 20. Global Ophthalmic Drugs market, company market share analysis (2023)